author-photo

Jennifer K DeMarco

University of Louisville

7

Papers

21

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2.

2021 Science
Show All
- Source
- Cite
- Save
Citations (17)
Serological assessment of SARS-CoV-2 infection during the first wave of the pandemic in Louisville Kentucky.

2021 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (2)
At the Intersection Between SARS-CoV-2, Macrophages and the Adaptive Immune Response: A Key Role for Antibody-Dependent Pathogenesis But Not Enhancement of Infection in COVID-19

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
CoV-RBD121-NP Vaccine Candidate Protects against Symptomatic Disease Following SARS-CoV-2 Challenge in K18-hACE2 Mice and Induces Protective Responses That Prevent COVID-19-Associated Immunopathology

2021 Vaccine
Show All
- Source
- Cite
- Save
Citations (0)